Lifestyle Boehringer Ingelheim Will Test an Obesity Medication in Three Late-Stage TrialsBy Gazet InternationalOctober 1, 20230 Germany’s leading pharmaceutical company Boehringer Ingelheim released a statement stating it would conduct three late-stage studies for its obesity drug candidate this Thursday after a result… Read More
